Oncology Central

Delivery of therapeutics using nanocarriers for targeting cancer cells and cancer stem cells


Development of cancer resistance, cancer relapse and metastasis are attributed to the presence of cancer stem cells (CSCs). Eradication of this subpopulation has been shown to increase life expectancy of patients. Since the discovery of CSCs a decade ago, several strategies have been devised to specifically target them but with limited success.

To view restricted content, please:

Leave A Comment